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Pterocellin A isolated from marine 
bryozoan Pterocella vesiculosa is cytotoxic 
to human HeLa cells via mitochondrial 
apoptotic processes
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Abstract 
Pterocellin A is a novel bioactive alkaloid isolated from the New Zealand marine bryozoan Pterocella vesiculosa. It 
exhibits potent antitumour activity towards the P388 (murine leukaemia) cell line in vitro and is selectively sensitive 
towards certain non-small cell lung, melanoma, and breast cancer cell lines, however, the biological mode of action 
of pterocellin A is unknown. Using the human cervical cancer cell line HeLa, we show that pterocellin A exhibited 
cytotoxicity against HeLa cells with an IC50 of 886 ng/mL. Time-course MTT and LDH assays were carried out and the 
results showed only a low level of cytosolic LDH was detected in the supernatant after all the cells have died from 
pterocellin A treatment at 2000 ng/mL. This indicated the cells maintained membrane integrity upon cell death which 
suggested apoptotic cell death. Additionally, morphological changes were observed under the microscope after 6 h 
of treatment. Cell shrinkage and nucleus condensation were observed, as well as apparent membrane blebbing, a 
key feature of apoptosis. The MTT data was also indicative of mitochondria impairment which could suggest that 
pterocellin A targets the mitochondria. This idea was supported by the observed changes in the morphology and 
location of the mitochondria after exposure to pterocellin A. Furthermore, the level of activated caspase-3 in HeLa 
cells increased after treatment with pterocellin A; activated caspase-3 can only be detected after a series of signalling 
events following the induction of apoptosis. These data support the notion that pterocellin A is an inducer of apopto-
sis in HeLa cells possibly via mitochondria related processes.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Natural products, also known as secondary metabo-
lites, are organic compounds produced by living organ-
isms. Unlike primary metabolites such as carbohydrates 
and amino acids, secondary metabolites are consid-
ered non-essential to life and have no apparent function 
within the organism (Williams et  al. 1989). These com-
pounds attract research interest because they can exert 
physiological effects on other organisms, often playing 
an ecological role in regulating a wide range of chemi-
cal interactions. These include pheromone chemical 
communication, chemical defence mechanisms, and 
mutualistic interactions between plants, microorganisms, 
insects and animals (Verpoorte 1998). Natural products 
are known for their characteristic chemical diversity, 
novelty and structural complexity, often containing unu-
sual combinations of functional groups which attribute 
to biochemical specificity and other molecular properties 
(Koehn and Carter 2005). Many bioactive compounds 
have been found to have therapeutic effects in humans. 
These properties thus make natural products ideal candi-
dates for lead compounds in drug discovery in the phar-
maceutical industry.
The rate of discovery of novel bioactive compounds 
from terrestrial organisms has decreased in recent years, 
due to an increased frequency of rediscovery (Dias et al. 
2012). This led to the search being extended to unex-
plored habitats in marine environments. The marine 
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environment is a rich source of biological and chemi-
cal biodiversity. The ocean covers greater than 70  % of 
the earth’s surface but the chemical resources from this 
environment are largely untapped (Donia and Hamann 
2003). Thirty-two of the thirty-three animal phyla are 
represented in aquatic environments and fifteen phyla 
are exclusive to the marine environment (Colegate 2007). 
Potential pharmaceutical leads from natural products are 
likely to be found in places with high biodiversity, such 
as the ocean fringe or coral reefs in marine environments 
(Hay and Fenical 1996). Marine natural products are 
often produced in sessile, colonial marine species such 
as soft-bodied invertebrates including sponges, bryo-
zoans, and tunicates. These organisms, living in such a 
highly competitive environment, have evolved to over-
come the ecological pressure to compete for space with 
surrounding species and to evade predators (Van Minh 
et  al. 2005). Due to their lack of movement and physi-
cal defence structures, it is thought that these organisms 
survive by utilising natural products as chemical defence 
mechanisms (Beesoo et al. 2014).
Bryozoans, commonly known as sea moss or moss ani-
mals, are sedentary, filter-feeding invertebrates found 
in aquatic environments. There are over 8000 species of 
bryozoans described, many more were observed in fos-
sil records (Pechenik 2014). Most species inhabit marine 
environments with very few in freshwater lakes and riv-
ers (Ryland 1970). Bryozoans are of particular research 
interest due to the variety of secondary metabolites they 
contain. A number of novel natural products from bryo-
zoans have been isolated to date. These have been exten-
sively reviewed (Blunt et al. 2015; Sharp et al. 2007).
Pterocellins are a class of novel alkaloids isolated from 
the marine bryozoan Pterocella vesiculosa collected off 
the coast of the North Island, New Zealand. Structures 
of pterocellins A–F (Fig.  1) have been elucidated by 
NMR spectroscopy and single-crystal X-ray diffraction 
(Prinsep 2008; Yao et al. 2003). Bioactivity testing of two 
pterocellins (A, B) indicated promising anti-bacterial, 
anti-tumour, and anti-fungal activities. It was found that 
pterocellins A and B were active against the P388 murine 
leukaemia cell line (IC50 values 477 and 323  ng/mL, 
respectively); non-small cell lung (NCI-H23), melanoma 
(MALME-3M, M14, SK-MEL-5), and breast (MDA-
MB-435, MDA-N) cell lines (Yao et  al. 2003). How-
ever, the mode of cytotoxicity of pterocellin A is not yet 
known. Since cytotoxic natural products that selectively 
target the apoptotic pathways of cancer cells are particu-
larly of interest in the development of chemotherapeutic 
agents. We investigated to see if pterocellin A was cyto-
toxic to the human cervical cancer cell line HeLa via 
apoptotic cell death processes.
Methods
HeLa cell culture
The human cervical cancer cell line, HeLa, was purchased 
from the American Tissue Culture Collection (ATCC) 
(Number CCL-2). The cells were grown in DMEM 
(25  mM d-Glucose, 4  mM  l-Glutamine, 1  mM sodium 
pyruvate, Gibco) supplemented with 100X units of peni-
cillin/streptomycin (Gibco) and 10 % foetal bovine serum 
(FBS) (Gibco). Cells were grown in T-25 flasks (Biofil) in 
standard incubation conditions in a humidified incuba-
tor (Heraeus HERAcell™) at 37  °C with 5  % CO2. Cells 
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Fig. 1 Structures of Pterocellins A–F
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were harvested and subcultured every 4  days at near 
confluency.
MTT assay
The Sigma thiazolyl blue tetrazolium bromide (MTT) 
reagent was used as per the manufacturer’s protocol. 
The MTT solution was freshly prepared before each 
experiment by dissolving in complete DMEM at a con-
centration of 5 mg/mL, pre-warmed to 37 °C and passed 
through a filter (0.2 μm) with a syringe. The solubilising 
solution was also freshly prepared to a final concentra-
tion of 0.1 M HCl in isopropanol.
Each experiment was carried out in triplicate samples 
in 96-well cell culture plates (Biofil). There were three 
controls in each experiment: growth control, negative 
control and solvent control. Growth control consisted 
of untreated cells in media; solvent control consisted 
of untreated cells in media, with the addition of MeOH 
equal to the solvent percentage of the highest treatment 
concentration and the negative control consisted of 
media plus solvent. The final solvent concentration did 
not exceed 2 % of the total volume. Near confluent cells 
in log-phase were harvested and seeded at a density of 
1 ×  104 cells per well, each well containing 150  μL cell 
culture. The cells were then incubated at standard con-
ditions overnight to allow the cells to attach and recover 
from handling before treatment was added. To carry out 
the assay, existing media containing test compound were 
removed and replaced with fresh media (150 μL per well). 
This was followed by the addition of reconstituted MTT 
in an amount equal to 10 % of the media volume (15 μL) 
and incubation at standard conditions for 2 h. The MTT 
media was then carefully removed and replaced with 
MTT solubilising solution in an amount equal to the 
original volume (150 μL) to dissolve the formazan crys-
tals. The samples were then placed on a plate-shaker 
(IKA® MS 1) for 15 min at room temperature, protected 
from light. Once homogenised, the samples were spec-
trophotometrically measured on a plate reader (Bio-Rad 
680) at an absorbance wavelength of 570  nm, with a 
background absorbance reading at 655 nm.
LDH assay
The LDH assays were carried out simultaneously to MTT 
assays using a CytoTox 96® Non-Radioactive Cytotoxic-
ity Assay commercial kit (Promega) as per the manufac-
turer’s protocol. The assay involved taking supernatant 
from treated cells without disturbing the cell population 
for MTT assay. The substrate mix used in the assay was 
reconstituted with assay buffer (12  mL) and stored at 
−20 °C for no more than 6–8 weeks protected from light. 
There were several controls included in these experi-
ments: spontaneous release control (SRC), maximum 
release control (MRC), and culture medium background 
control (CM). Spontaneous control corrected for the 
spontaneous release of LDH from cells; maximum con-
trol represented 100 % release of LDH upon cell lysis and 
culture medium background control corrected for any 
LDH activity contributed by FBS in the DMEM, and the 
varying amounts of phenol red in the media. The growth 
control from MTT assays served the same purpose as the 
spontaneous control in LDH assays.
Cells were incubated with test compound as per 
experimental protocol. Prior to harvesting supernatant, 
15 μL of lysis solution (10X) was added to the maximum 
release control. This allowed total cell lysis and there-
fore the release of total LDH into the supernatant. After 
incubating for 45 min, the maximum release control was 
checked under the microscope to confirm complete lysis. 
The culture plate was then centrifuged (Heraeus™ Mul-
tifuge™ X3) at 250×g at room temperature for 4 min to 
pellet any cell debris.
To carry out the assay, 50  μL supernatant from each 
sample of the culture plate was transferred to a new assay 
plate (Greiner Bio-One). The reconstituted Substrate Mix 
was then brought to room temperature and 50 μL was 
added to each sample. This was incubated for 30 min at 
room temperature (protected from light using foil), fol-
lowed by the addition of Stop Solution (50  μL) to each 
sample. The samples were measured on a plate reader 
(Bio-Rad 680) at an absorbance of 490 nm within an hour 
of adding the stop solution.
Caspase‑3(active) assay
This assay was carried out using a commercial kit Cas-
pase-3 (active) FITC Staining Kit (Abcam) as per the 
manufacturer’s protocol with small modifications. Near 
confluent cells in log-phase were harvested and seeded 
at a density of 3  ×  105 in a 6-well cell culture plate 
(Greiner Bio-One). The cells were then incubated at 
standard incubation conditions overnight to allow the 
cells to attach and recover from handling before treat-
ment was added. After treatment, the media from each 
well was transferred to Falcon tubes (15  mL) to collect 
any detached cells from treatment. The remaining cells 
were harvested by washing with pre-warmed PBS (1 mL) 
followed by the addition of trypsin/EDTA (0.5 mL). Once 
detached, pre-warmed DMEM (1.5  mL) was added to 
each well to neutralise trypsin before being transferred 
to the corresponding Falcon tubes. An aliquot (100  μL) 
was then taken from each sample for a cell count. The 
remaining cells were centrifuged at 800×g for 5  min, 
and the cell pellets were re-suspended in pre-warmed 
DMEM (1  mL). To measure the fluorescent activity of 
caspase-3, FITC-DEVD-FMK (1  μL) was added to ali-
quots (30 μL) of each sample in Eppendorf tubes (1.5 mL) 
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and incubated at standard incubation conditions for 1 h. 
After incubation, the cells were centrifuged at 3000 rpm 
for 5 min and the supernatant was removed. Wash Buffer 
(0.5 mL) was then added followed by centrifugation; and 
this step was repeated. Finally, the cell pellet was re-
suspended in Wash Buffer (100  μL) then transferred to 
a black microtitre plate (Greiner Bio-One). The fluores-
cence intensity was measured on a plate reader (BMG 
Fluostar Optima) at excitation and emission wavelengths 
of 485 and 520 nm respectively.
Confocal fluorescent microscopy
Fluorescent microscopy work was carried out on an 
Olympus FV1000 laser scanning confocal microscope. 
The staining and visualisation of the mitochondria uti-
lised a fluorescent dye, MitoTracker Red CMXRos which 
has peak absorption and emission at 578 and 599  nm 
respectively, producing a red fluorescence.
A stock solution (1 mM) was made up according to the 
manufacturer’s manual by adding DMSO (94 μL) to a vial 
(50 μg) of MitoTracker Red CMXRos at room tempera-
ture. An aliquot (10 μL) was made up to 1 μM with com-
plete DMEM (9.99 mL) and stored in the dark at −20 °C. 
The working solutions (50 nM) were prepared fresh from 
the 1 μM stock solution before each experiment.
To visualise mitochondria under fluorescence, cells 
were grown in a Fluorodish™ (WPI) and stained with 
working solution under standard conditions for 20 min. 
The staining media was then replaced with fresh media 
and cells were incubated for a further 10  min to wash 
away unincorporated dye.
Statistical analysis
All statistical analyses were carried out using Microsoft 
Excel. Data was averaged where appropriate, and the 
standard error of the mean (S.E.M) was calculated using 
Excel. A two-tailed Student’s t test was carried out to 
determine the significance of the data, and the accepted 
level of significance was p < 0.05, which was denoted as 
“*”.
Results
After 24 h incubation, HeLa cells treated with pterocellin 
A had an IC50 value of 886 ng/mL, which was within the 
same order of magnitude as the IC50 of pterocellin A with 
the P388 cell line noted in a previous study (Yao et  al. 
2003). Interestingly the relative inhibition of cells treated 
with the lower concentrations decreased over this time 
which attributed to the higher IC50 values (Fig.  2). This 
suggests the cells were able to recover and overcome the 
cytotoxic effects of pterocellin A after a period of time.
LDH assays were carried out to find out if the decrease 
in cell viability affected the plasma membrane integrity. 
Based on the MTT assay, it was found that there was a 
steady increase in relative inhibition as the concentration 
increased, however the level of detected LDH remained 
relatively low. All cells were killed at 2000  ng/mL after 
24 h, and the amount of LDH released was 29.54 % (Fig. 3).
A basic trypan blue exclusion cell count can distin-
guish between dead and live cells. Stained cells observed 
under the microscope would indicate a cell with a com-
promised plasma membrane. A trypan blue exclusion cell 
count was carried out after treating cells with different 
Fig. 2 Pterocellin A toxicity against HeLa cells after 24, 48 and 72 h treatment, MTT assay. Bar graph showing the mean ± S.E.M, *p < 0.05, N = 3
Page 5 of 11Wang et al. SpringerPlus  (2016) 5:742 
concentrations of pterocellin A for 24 h. It was found that 
no stained cells were observed after treatment, the cell 
number steadily decreased as the concentration of ptero-
cellin A increased (Fig. 4).
The morphology of the cells started to change after 6 h 
of incubation in the presence of pterocellin A (Fig.  5). 
Compared to the untreated normal cells which appeared 
elongated and had contact with neighbouring cells, cells 
treated with pterocellin A appeared to have lost the 
contact and became round. The nuclei had become con-
densed and were no longer visible.
The presence of apoptotic cells was evident when 
observed under differential interference contrast (DIC) 
of a confocal microscope. Membrane blebbing, a charac-
teristic of cells undergoing apoptosis could be seen. Some 
cells appeared to be ‘shrinking’, and apoptotic ‘spikes’ 
were also observed. After 24 h treatment, cells were com-
pletely detached (Fig. 6a, b).
Fig. 3 Pterocellin A toxicity against HeLa cells at 24 h treatment, MTT and LDH assays. Bar graph showing the mean ± S.E.M, *p < 0.05, N 
(MTT) = 12; N (LDH) = 6
Fig. 4 Trypan blue exclusion cell count after 24 h treatment. Bar graph showing the mean ± S.E.M, N = 3
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To investigate the effects of pterocellin A on mitochon-
dria, cells were stained with MitoTracker Red CMXRos 
and visualised by a laser confocal fluorescent microscope. 
MitoTracker Red CMXRos is a membrane-permeable 
fluorescent dye used to label mitochondria. It contains 
a mildly thiol-reactive chloromethyl moiety that reacts 
with thiol groups of the proteins in the mitochondria 
(Poot et al. 1996).
After treatment with pterocellin A (1000  ng/mL), the 
mitochondria re-distributed from the cell cytoplasm to 
the peri-nuclear region after 6 h (Fig. 7). This localisation 
took place before any notable changes in cell morphology 
and cell death as shown in the overlay images. Compared 
to healthy mitochondria that have an elongated tubular 
formation, the mitochondria of treated cells appeared to 
be fragmented and ‘swollen’. These changes in the loca-
tion and morphology of the mitochondria have been 
reported in the literature including in HeLa cells during 
UV-induced apoptosis and in pig kidney (PEK) cells after 
treatment with rotenone, an inhibitor of the respiratory 
complex I (Modok et al. 2006; Silva 2010; Skulachev et al. 
2004; Gao et al. 2001). It was also found that the thread-
grain transition occurred after the release of cytochrome 
c from the mitochondria upon induction of apoptosis 
(Silva 2010). These distinct morphological changes fur-
ther supported the idea that pterocellin A was an inducer 
of apoptosis in HeLa cells.
Another piece of evidence supporting apoptotic cell 
death was the activation of caspase-3 detected after treat-
ment by pterocellin A in HeLa cells. Activated caspase-3 
is only present upon the induction of apoptosis (Krysko 
et al. 2008). Upon treatment by pterocellin A (at both 500 
and 1000 ng/mL), the level of activated caspase-3 meas-
ured by FITC fluorescent staining increased by approxi-
mately 2.5-fold compared to untreated control cells 
(Fig. 8).
Discussion
A number of MTT and LDH assays were performed dur-
ing this study. MTT assay was used to determine the cell 
viability after treatment with pterocellin A. The MTT 
cell viability assay measures the reduction of MTT, a 
water-soluble tetrazolium dye, to insoluble formazan 
crystals. This reduction reaction is dependent on the 
activity of functioning cellular dehydrogenases in living 
cells, thus is an indicator of cell viability and mitochon-
dria activity (Berridge et  al. 2005). The LDH assay is a 
colorimetric assay that detects the loss of cell membrane 
integrity by measuring the release of cytosolic enzyme 
LDH into extracellular space upon cell lysis. Similar to 
the MTT assay, the LDH assay involves the enzymatic 
conversion of a tetrazolium salt, INT [2-(4-iodophenyl)-
3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride], 
into a water-soluble red formazan product. The amount 
of colour formation is proportional to the amount of cell 
lysis (Krysko et al. 2008).
Initial experimental data showed that pterocellin A 
affected cell viability significantly (p < 0.05) within 24 h 
of treatment in HeLa cells. A longer treatment period did 
not increase the cytotoxicity, as 100 % of the cells were no 
longer viable at concentrations above 3125 ng/mL. Inter-
estingly, cells that survived the first 24 h at the lower con-
centration range had lower relative inhibition values after 
48 and 72 h as demonstrated by the IC50 values. This sug-
gests that the cells were able to proliferate and overcome 
the cytotoxic effects after the first 24 h.
The first evidence that suggested that the cells were 
undergoing apoptosis was demonstrated by the differ-
ence in the relative inhibition from the MTT and LDH 
assays. These assays showed that after 24 h, all cells were 
killed at 2000 ng/mL according to the MTT data and also 
by visual observation. However, the LDH data showed 
only a small increase in the level of detected LDH. The 
elevated LDH was likely due to a process known as sec-
ondary necrosis; this occurs when the apoptotic cells 
have died but have not been eliminated (Silva 2010).
Time-course experiments of pterocellin A showed 
that changes in HeLa cells after exposure to pterocellin 
A were detectable in just after 3 h. Although visually the 
cell morphology displayed no change, detectable changes 
were observed in the MTT data. Since MTT is also an 
indicator of mitochondrial dehydrogenase function (Ber-
ridge et al. 2005), this suggests that there was a degree of 
mitochondria impairment attributed to the cytotoxicity 
(See figure on previuos page.) 
Fig. 5 Images of cells treated at different concentrations of pterocellin A at different times Photos taken at ×200 magnification using an inverted 
Nikon eclipse TS100 microscope with a Nikon COOLPIX 4500 camera
(See figure on next page.)  
Fig. 6 a Changes in cell morphology after treatment with pterocellin A at 2000 ng/mL. Black arrows pointing at examples of apoptotic features. 
(Photos taken at ×200 magnification using an inverted Nikon eclipse TS100 microscope with a Nikon COOLPIX 4500 camera). b DIC images of a 
single apoptotic cell from the same experiment. a 1 Growth control. 2 Cells treated at 1000 ng/mL for 6 h. (Photos were obtained from an Olympus 
FV1000 confocal microscope at ×400 magnification)
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Fig. 7 Changes in mitochondrial morphology after pterocellin A treatment at 1000 ng/mL after 6 and 12 h. a Mitochondria stained with 50 nM 
MitoTracker Red CMXRos (Em. 599 nm). b Overlay of stained mitochondria and phase contrast images Photos obtained from the Olympus FV1000 
laser scanning confocal microscope at ×400 magnification
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Fig. 8 Caspase-3 activity of treated cells compared to control. Bar graph showing the mean ± S.E.M, N = 6
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of pterocellin A. Elevated LDH release was only apparent 
after 12 h treatment at 2000 ng/mL when the cells were 
almost 90  % inhibited, this further suggest that second-
ary necrosis took place to some extent after the apoptotic 
cells had already died.
The trypan blue exclusion experiment indicated that 
neighbouring cells were indeed taking up apoptotic cells 
after death as no cells were observed in the cell count, 
even after collecting supernatant during harvest. How-
ever, when observed under the microscope straight after 
treatment, cell debris could be seen floating in the cul-
ture medium after 24 h. These were just cell debris and 
not intact dead cells, as they did not show up during the 
trypan blue exclusion cell count. Presence of cell debris 
indicated that some degree of cell lysis took place in the 
form of secondary necrosis after apoptotic cells had been 
phagocytosed.
Further evidence of HeLa cells undergoing apoptosis 
after exposure to pterocellin A was the morphological 
changes observed. After 6  h treatment of 2000  ng/mL, 
it became obvious when observed under the microscope 
that cells were affected. Treated cells were no longer 
attached to their neighbouring cells compared to the 
control, the nucleus was no longer visible and the cells 
also appeared to ‘shrink’. This shrinking was due to con-
densation of the nucleus, another character of apoptosis. 
Additionally, apoptotic spikes and membrane blebbing 
were also observed within 6  h of treatment. Time-lapse 
images taken under DIC on a confocal laser microscope 
displayed movement of the apoptotic blebs as the cells 
undergo apoptosis (data not shown).
The MitoTracker staining of the mitochondria showed 
that the mitochondrial morphology changed after 6  h 
of treatment. In healthy cells, the mitochondria appear 
elongated and filamentous; after exposure to pterocel-
lin A, distinct changes were observed under a confocal 
laser microscope. Mitochondria are normally distributed 
throughout the cytoplasm, however it was found that the 
mitochondria redistributed from the cell periphery and 
localised around the nucleus after treatment with ptero-
cellin A. This change took place before changes in cell 
morphology were observed. The overlay images showed 
that at 1000 ng/mL after 6 h, the cells still appeared nor-
mal compared to the control, however changes in the 
mitochondria were obvious.
Marine natural products have become important 
sources in the discovery of antitumour drugs. Cytotoxic 
natural products that selectively target the apoptotic 
pathways of cancer cells are particularly of interest in 
the development of chemotherapeutic agents. There are 
limited numbers of cytotoxicity studies on marine natu-
ral products. Some examples from the literature include: 
Mycalamide A and pateamine isolated from marine 
sponges of the Mycale genus collected from New Zea-
land (Hood et  al. 2001). In preliminary screening, both 
compounds have been shown to be apoptotic inducers in 
H441, LLC-PK1 and SY5Y cells (Hood et al. 2001). Glio-
toxin is a natural product produced by the marine fun-
gus Aspergillus sp. and has been shown to be cytotoxic 
to HeLa and human chondrosarcoma (SW1353) cells via 
apoptotic processes (Nguyen et al. 2014). The induction 
of apoptosis in HeLa cells by Physcion, an anthraqui-
none derivative isolated from the marine-derived fun-
gus Microsporum sp. has also been reported (Wijesekara 
et  al. 2014). A cyclic peptide microsclerodermin A iso-
lated from the sponge Amphibleptula has recently been 
shown to induce apoptosis in the AsPC-1, BxPC-3 and 
the PANC-1 cell lines (Guzmán et  al. 2015). Heterone-
min, a bioactive marine sesterterpene isolated from the 
sponge Hyrtios sp. has been shown to lead to apoptotic 
cell death in three human cancer cell lines (A549, ACHN, 
and A498) (Wu et al., 2015).
We have demonstrated for the first time that pterocel-
lin A, a novel alkaloid isolated from the marine bryozoan 
Pterocella vesiculosa collected off the coast of the North 
Island, New Zealand is cytotoxic to HeLa human cancer 
cells via apoptotic cellular death processes.
Conclusions
We present evidence which suggest that pterocellin A 
could be acting on mitochondria via the intrinsic path-
way, however due to the complex nature of the signalling 
cascades, it is not yet known how the compound enters 
the cell and which pathway it is interacting with. Out 
of all the pterocellins, only those with no substitution 
at position 8, such as pterocellins A and B, exerted the 
highest antitumour activity against P388 cells (Yao et al. 
2003). It could be that the biological interaction of ptero-
cellins is size-dependent. The backbone ring structure 
could be intercalating with DNA and prompting apopto-
sis. It is also possible that if pterocellin A is able to tar-
get and enter the mitochondria, the mitochondrial DNA 
(mtDNA) could be more susceptible to damage due to 
the lack of histone proteins that are normally present in 
nuclear DNA as regulatory proteins (Brown et al. 1979). 
Further elucidation of the role of mitochondria as cellular 
targets for pterocellin A will give insights into the viabil-
ity of pterocellin A as a lead compound for pharmaceuti-
cal development.
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